All individual trials at MDbackline, LLC

0 out of 1

0.0%

$29,605,071

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	MDbackline, LLC	NCT02752646	Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5% [pACT]	2017-03-01	2589

Download this data